MRSN
Mersana Therapeutics (MRSN)
$60
About Mersana Therapeutics (MRSN)
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA.
Details
Daily high
$1.68
Daily low
$1.56
Price at open
$1.68
52 Week High
$6.28
52 Week Low
$1.22
Market cap
197.7M
Dividend yield
0.00%
Volume
2.7M
Avg. volume
1.4M
P/E ratio
-2.61
Mersana Therapeutics News
Details
Daily high
$1.68
Daily low
$1.56
Price at open
$1.68
52 Week High
$6.28
52 Week Low
$1.22
Market cap
197.7M
Dividend yield
0.00%
Volume
2.7M
Avg. volume
1.4M
P/E ratio
-2.61